Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria

Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma

(2016) P Ravi et al.   Blood Cancer Journal

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

(2014) S Vincent Rajkumar et al.   LANCET ONCOLOGY

The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma

(2014) E Kastritis et al.   LEUKEMIA

Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)

(2013) M. V. Dhodapkar et al.   BLOOD

Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review

(2013) Josien C. Regelink et al.   BRITISH JOURNAL OF HAEMATOLOGY

Progression in Smoldering Myeloma Is Independently Determined by the Chromosomal Abnormalities del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load

(2013) Kai Neben et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma

(2013) S V Rajkumar et al.   LEUKEMIA

Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

(2013) María-Victoria Mateos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma

(2012) J T Larsen et al.   LEUKEMIA

Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease

(2012) E Kastritis et al.   LEUKEMIA

Diagnosis of Smoldering Multiple Myeloma

(2011) S. Vincent Rajkumar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence and follow-up of asymptomatic multiple myeloma.

(2010) F. Wisløff et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma

(2010) Jens Hillengass et al.   JOURNAL OF CLINICAL ONCOLOGY

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

(2010) R A Kyle et al.   LEUKEMIA

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

(2007) A. Dispenzieri et al.   BLOOD